2017 Archived Press Releases

2017 Archived Press Releases

Webcast ImageWebcast
Pacira Pharmaceuticals, Inc. at the BMO Capital Markets: Prescriptions for Success Healthcare Conference  (Replay)
12/14/17 at 11:30 a.m. ET
Pacira Pharmaceuticals, Inc. at the BMO Capital Markets: Prescriptions for Success Healthcare Conference
Thursday, December 14, 2017 11:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Illinois Surgical Quality Improvement Collaborative and Pacira Pharmaceuticals, Inc. Announce Collaboration to Minimize Opioid Exposure for Postsurgical Patients
12/14/17
Pacira Pharmaceuticals to Present at the 2017 BMO Capital Markets Prescriptions for Success Healthcare Conference
12/08/17
Pacira Announces Promotions of Scott Braunstein, MD, to Chief Operating Officer and Richard Scranton, MD, to Chief Scientific Officer
12/07/17
Cancer Treatment Centers of America® Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opioid Use
11/29/17
Pacira Announces FDA Advisory Committee Meeting to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
11/14/17
Pacira Pharmaceuticals to Present at Two November Healthcare Conferences
11/09/17
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2017 Financial Results
11/08/17
Pacira Pharmaceuticals Announces Timing for Third Quarter 2017 Financial Results Webcast and Conference Call
10/31/17
Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement
10/25/17
Pacira Pharmaceuticals Announces FDA Acceptance of sNDA for EXPAREL as a Nerve Block to Produce Regional Analgesia
10/18/17
Pacira Pharmaceuticals CEO to Testify at White House Opioid Crisis Commission Meeting
09/27/17
New Research: Overprescribing of Postsurgical Opioids Poses a Serious Threat to Patients and their Communities; Women Undergoing Surgery are at Greatest Risk
09/26/17
Pacira Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
09/20/17
Pacira Pharmaceuticals, Aetna, and the American Association of Oral and Maxillofacial Surgeons Join Together in a Program to Reduce Opioid Exposure for Patients Undergoing Wisdom Tooth Extraction
09/13/17
Pacira Pharmaceuticals Announces Multiple EXPAREL Data Presentations at the Upcoming New York School of Regional Anesthesia Annual Fall Symposium
09/06/17
Pacira Pharmaceuticals to Present at the 2017 H.C. Wainwright 19th Annual Global Investment Conference
09/05/17
Pacira Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference
08/31/17
Pacira Pharmaceuticals to Present at the 2017 Wedbush Pacgrow Healthcare Conference
08/09/17
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial Results
08/02/17
Pacira Announces Publication of Phase 4 Study of EXPAREL in Patients Undergoing Total Knee Replacement in The Journal of Arthroplasty
07/26/17
Pacira Pharmaceuticals Announces Timing for Second Quarter 2017 Financial Results Webcast and Conference Call
07/25/17
Pacira Announces Topline Phase 3 Results for EXPAREL® as a Single-dose Nerve Block
07/25/17
Pacira Pharmaceuticals Appoints Mark I. Froimson, M.D., to Board of Directors
06/15/17
Pacira Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
06/14/17
Pacira Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
06/01/17
Pacira Pharmaceuticals Announces Resignation of James Scibetta
05/23/17
Pacira Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference
05/10/17
Pacira Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results
05/04/17
New Research Shows Vast Majority of Oral Surgery Patients Would Choose Non-opioid Medication to Treat Postsurgical Pain if Given the Option
05/03/17
Pacira Pharmaceuticals Announces Timing for First Quarter 2017 Financial Results Webcast and Conference Call
04/27/17
Pacira Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference
04/03/17
Trinity Health and Pacira Pharmaceuticals Announce Collaboration to Decrease Opioid Use Nationwide
03/16/17
Phase 4 Study Shows EXPAREL® Versus an Active Comparator Significantly Reduces Opioid Consumption and Postsurgical Pain in Patients Undergoing Total Knee Arthroplasty
03/14/17
Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
03/13/17
Pacira Pharmaceuticals Announces Pricing of $300 Million Aggregate Principal Amount of 2.375% Convertible Senior Notes due 2022
03/07/17
Pacira Pharmaceuticals Announces Proposed Offering of $300 Million Aggregate Principal Amount of Convertible Senior Notes
03/06/17
Pacira Pharmaceuticals Reports 2016 Financial Results and Provides Business Update
03/01/17
Pacira Pharmaceuticals Announces Timing for 2016 Financial Results Webcast and Conference Call
02/16/17
Pacira Pharmaceuticals, Inc. to Present at the 2017 RBC Capital Markets’ Healthcare Conference
02/15/17
Pacira Pharmaceuticals Announces Collaboration with DePuy Synthes to Support Promotion, Education and Training of EXPAREL® in Orthopedics
01/25/17
Pacira Pharmaceuticals Reports Preliminary 2016 Revenues of $276.4 Million
01/06/17
Pacira Pharmaceuticals, Inc. to Present at the 35th Annual J.P. Morgan Healthcare Conference
01/03/17